Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
February-2023 Volume 25 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
February-2023 Volume 25 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data.pdf
Article Open Access

Salidroside protects against intestinal barrier dysfunction in septic mice by regulating IL‑17 to block the NF‑κB and p38 MAPK signaling pathways

  • Authors:
    • Rongxin Liao
    • Peng Zhao
    • Jianming Wu
    • Keren Fang
  • View Affiliations / Copyright

    Affiliations: Center of Traditional Chinese Medicine Preventive Treatment, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, Guangdong 510310, P.R. China
    Copyright: © Liao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 89
    |
    Published online on: January 5, 2023
       https://doi.org/10.3892/etm.2023.11788
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Sepsis is a systemic inflammatory response syndrome, mainly caused by infection or suspected infectious factors. The intestine is not only one of the most easily involved organs in the course of sepsis, but also the dynamic organ for the course of sepsis. The present study investigated the protective effect and mechanism of salidroside on intestinal barrier dysfunction of septic mice. Briefly, C57BL/6 mice were used to establish a septic model and then administered with salidroside. The ileum tissues of mice were examined by histopathological examination. Fluorescein isothiocyanate‑dextran concentration was measured. IL‑17, IL‑6, IL‑13 and TNF‑α levels in ileum tissues and NF‑κB and p38 MAPK activations were detected by ELISA and the expressions of NF‑κB p65 and p38 MAPK protein with their phosphorylation and intestinal tight junction proteins were gauged by western blotting. The above assays were performed again to investigate the effect of anti‑IL‑17A and salidroside (160 mg/kg) alone or in combination. The septic model induced the ileum tissue injury, increased intestinal permeability and TNF‑α, IL‑17 and IL‑6 levels, activated NF‑κB and p38 MAPK pathways, promoted the expressions of NF‑κB p65 and p38 MAPK and their phosphorylation, while suppressing the levels of IL‑13 and intestinal tight junction proteins. Salidroside and anti‑IL‑17A partially reversed the above effects of septic model, which in combination further strengthened the reversing effect. Collectively, salidroside protected against intestinal barrier dysfunction in septic mice by downregulating IL‑17 level to inhibit NF‑κB and p38 MAPK signaling pathways, thus providing a new treatment direction.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

View References

1 

Shankar-Hari M, Phillips GS, Levy ML, Seymour CW, Liu VX, Deutschman CS, Angus DC, Rubenfeld GD and Singer M: Developing a new definition and assessing new clinical criteria for septic shock: For the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 315:775–787. 2016.PubMed/NCBI View Article : Google Scholar

2 

Deutschman CS and Tracey KJ: Sepsis: Current dogma and new perspectives. Immunity. 40:463–475. 2014.PubMed/NCBI View Article : Google Scholar

3 

Hawiger J, Veach RA and Zienkiewicz J: New paradigms in sepsis: From prevention to protection of failing microcirculation. J Thromb Haemost. 13:1743–1756. 2015.PubMed/NCBI View Article : Google Scholar

4 

Adib-Conquy M and Cavaillon JM: Host inflammatory and anti-inflammatory response during sepsis. Pathol Biol (Paris). 60:306–313. 2012.PubMed/NCBI View Article : Google Scholar : (In French).

5 

de Medina FS, Romero-Calvo I, Mascaraque C and Martínez-Augustin O: Intestinal inflammation and mucosal barrier function. Inflamm Bowel Dis. 20:2394–2404. 2014.PubMed/NCBI View Article : Google Scholar

6 

Panossian A, Wikman G and Sarris J: Rosenroot (Rhodiola rosea): Traditional use, chemical composition, pharmacology and clinical efficacy. Phytomedicine. 17:481–493. 2010.PubMed/NCBI View Article : Google Scholar

7 

Xue F, Yang M and Ma L: Microbial synthesis of salidroside. Sheng Wu Gong Cheng Xue Bao. 35:1184–1192. 2019.PubMed/NCBI View Article : Google Scholar

8 

Zhou F, Ju J, Fang Y, Fan X, Yan S, Wang Q, Wei P, Duan F, Miao F, Hu Z and Wang M: Salidroside protected against MPP(+)-induced Parkinson's disease in PC12 cells by inhibiting inflammation, oxidative stress and cell apoptosis. Biotechnol Applied Biochem. 66:247–253. 2019.PubMed/NCBI View Article : Google Scholar

9 

Xu N, Huang F, Jian C, Qin L, Lu F, Wang Y, Zhang Z and Zhang Q: Neuroprotective effect of salidroside against central nervous system inflammation-induced cognitive deficits: A pivotal role of sirtuin 1-dependent Nrf-2/HO-1/NF-κB pathway. Phytother Res. 33:1438–1447. 2019.PubMed/NCBI View Article : Google Scholar

10 

Zhong Z, Han J, Zhang J, Xiao Q, Hu J and Chen L: Pharmacological activities, mechanisms of action, and safety of salidroside in the central nervous system. Drug Des Devel Ther. 12:1479–1489. 2018.PubMed/NCBI View Article : Google Scholar

11 

Hu R, Wang MQ, Ni SH, Wang M, Liu LY, You HY, Wu XH, Wang YJ, Lu L and Wei LB: Salidroside ameliorates endothelial inflammation and oxidative stress by regulating the AMPK/NF-κB/NLRP3 signaling pathway in AGEs-induced HUVECs. Eur J Pharmacol. 867(172797)2020.PubMed/NCBI View Article : Google Scholar

12 

Zhong ZF, Han J, Zhang JZ, Xiao Q, Chen JY, Zhang K, Hu J and Chen LD: Neuroprotective effects of salidroside on cerebral ischemia/reperfusion-induced behavioral impairment involves the dopaminergic system. Front Pharmacol. 10(1433)2019.PubMed/NCBI View Article : Google Scholar

13 

Liu MW, Su MX, Qin LF, Liu X, Tian ML, Zhang W and Wang YH: Effect of salidroside on lung injury by upregulating peroxisome proliferator-activated receptor γ expression in septic rats. Exp Ther Med. 7:1446–1456. 2014.PubMed/NCBI View Article : Google Scholar

14 

Yasuda K, Takeuchi Y and Hirota K: The pathogenicity of Th17 cells in autoimmune diseases. Semin Immunopathol. 41:283–297. 2019.PubMed/NCBI View Article : Google Scholar

15 

Gu C, Wu L and Li X: IL-17 family: Cytokines, receptors and signaling. Cytokine. 64:477–485. 2013.PubMed/NCBI View Article : Google Scholar

16 

Monin L and Gaffen SL: Interleukin 17 family cytokines: Signaling mechanisms, biological activities, and therapeutic implications. Cold Spring Harbor perspect Biol. 10(a028522)2018.PubMed/NCBI View Article : Google Scholar

17 

Kuwabara T, Ishikawa F, Kondo M and Kakiuchi T: The role of IL-17 and related cytokines in inflammatory autoimmune diseases. Mediators Inflamm. 2017(3908061)2017.PubMed/NCBI View Article : Google Scholar

18 

Brembilla NC, Senra L and Boehncke WH: The IL-17 family of cytokines in psoriasis: IL-17A and beyond. Front Immunol. 9(1682)2018.PubMed/NCBI View Article : Google Scholar

19 

Lubberts E: IL-17/Th17 targeting: On the road to prevent chronic destructive arthritis? Cytokine. 41:84–91. 2008.PubMed/NCBI View Article : Google Scholar

20 

Lubberts E, Koenders MI, Oppers-Walgreen B, van den Bersselaar L, Coenen-de Roo CJ, Joosten LA and van den Berg WB: Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum. 50:650–659. 2004.PubMed/NCBI View Article : Google Scholar

21 

Li J, Kong P, Chen C, Tang J, Jin X, Yan J and Wang Y: Targeting IL-17A improves the dysmotility of the small intestine and alleviates the injury of the interstitial cells of cajal during sepsis. Oxid Med Cell Longev. 2019(1475729)2019.PubMed/NCBI View Article : Google Scholar

22 

Lee JS, Tato CM, Joyce-Shaikh B, Gulen MF, Cayatte C, Chen Y, Blumenschein WM, Judo M, Ayanoglu G, McClanahan TK, et al: Interleukin-23-independent IL-17 production regulates intestinal epithelial permeability. Immunity. 43:727–738. 2015.PubMed/NCBI View Article : Google Scholar

23 

Wei L, Xiong H, Li W, Li B and Cheng Y: Upregulation of IL-6 expression in human salivary gland cell line by IL-17 via activation of p38 MAPK, ERK, PI3K/Akt, and NF-κB pathways. J Oral Pathol Med. 47:847–855. 2018.PubMed/NCBI View Article : Google Scholar

24 

Chang SL, Hsiao YW, Tsai YN, Lin SF, Liu SH, Lin YJ, Lo LW, Chung FP, Chao TF, Hu YF, et al: Interleukin-17 enhances cardiac ventricular remodeling via activating MAPK pathway in ischemic heart failure. J Mol Cell Cardiol. 122:69–79. 2018.PubMed/NCBI View Article : Google Scholar

25 

Wei L, Liu M, Xiong H and Peng B: Up-regulation of IL-23 expression in human dental pulp fibroblasts by IL-17 via activation of the NF-κB and MAPK pathways. Int Endod J. 51:622–631. 2018.PubMed/NCBI View Article : Google Scholar

26 

Johansen C, Kragballe K, Westergaard M, Henningsen J, Kristiansen K and Iversen L: The mitogen-activated protein kinases p38 and ERK1/2 are increased in lesional psoriatic skin. Br J Dermatol. 152:37–42. 2005.PubMed/NCBI View Article : Google Scholar

27 

Chen H, Wang X, Yan X, Cheng X, He X and Zheng W: LncRNA MALAT1 regulates sepsis-induced cardiac inflammation and dysfunction via interaction with miR-125b and p38 MAPK/NFκB. Int Immunopharmacol. 55:69–76. 2018.PubMed/NCBI View Article : Google Scholar

28 

Cai X, Chen Y, Xie X, Yao D, Ding C and Chen M: Astaxanthin prevents against lipopolysaccharide-induced acute lung injury and sepsis via inhibiting activation of MAPK/NF-κB. Am J Transl Res. 11:1884–1894. 2019.PubMed/NCBI

29 

Lan KC, Chao SC, Wu HY, Chiang CL, Wang CC, Liu SH and Weng TI: Salidroside ameliorates sepsis-induced acute lung injury and mortality via downregulating NF-κB and HMGB1 pathways through the upregulation of SIRT1. Sci Rep. 7(12026)2017.PubMed/NCBI View Article : Google Scholar

30 

Zhang XR, Fu XJ, Zhu DS, Zhang CZ, Hou S, Li M and Yang XH: Salidroside-regulated lipid metabolism with down-regulation of miR-370 in type 2 diabetic mice. Eur J Pharmacol. 779:46–52. 2016.PubMed/NCBI View Article : Google Scholar

31 

Yang ZR, Wang HF, Zuo TC, Guan LL and Dai N: Salidroside alleviates oxidative stress in the liver with non-alcoholic steatohepatitis in rats. BMC Pharmacol Toxicol. 17(16)2016.PubMed/NCBI View Article : Google Scholar

32 

Uhle F, Lichtenstern C, Brenner T and Weigand MA: Pathophysiology of sepsis. Anasthesiol Intensivmed Notfallmed Schmerzther. 50:114–122. 2015.PubMed/NCBI View Article : Google Scholar

33 

Hu Q, Ren H, Li G, Wang D, Zhou Q, Wu J, Zheng J, Huang J, Slade DA, Wu X and Ren J: STING-mediated intestinal barrier dysfunction contributes to lethal sepsis. EBioMedicine. 41:497–508. 2019.PubMed/NCBI View Article : Google Scholar

34 

Liu S, Yu X, Hu B, Zou Y, Li J, Bo L and Deng X: Salidroside rescued mice from experimental sepsis through anti-inflammatory and anti-apoptosis effects. J Surg Res. 195:277–283. 2015.PubMed/NCBI View Article : Google Scholar

35 

He H, Chang X, Gao J, Zhu L, Miao M and Yan T: Salidroside mitigates sepsis-induced myocarditis in rats by regulating IGF-1/PI3K/Akt/GSK-3β signaling. Inflammation. 38:2178–2184. 2015.PubMed/NCBI View Article : Google Scholar

36 

Liu F, Liu J, Liu Y, Zhang Y and Ding X: Shen-Fu Decoction could ameliorate intestinal permeability by regulating the intestinal expression of tight junction proteins and p-VASP in septic rats. J Ethnopharmacol. 268(113562)2021.PubMed/NCBI View Article : Google Scholar

37 

Wang L, Cui YL, Zhang Z, Lin ZF and Chen DC: Rhubarb monomers protect intestinal mucosal barrier in sepsis via junction proteins. Chin Med J (Engl). 130:1218–1225. 2017.PubMed/NCBI View Article : Google Scholar

38 

Li Y, Guo R, Zhang M, Chen P, Li J and Sun Y: Protective effect of emodin on intestinal epithelial tight junction barrier integrity in rats with sepsis induced by cecal ligation and puncture. Exp Ther Med. 19:3521–3530. 2020.PubMed/NCBI View Article : Google Scholar

39 

Kumar V and Sharma A: Innate immunity in sepsis pathogenesis and its modulation: New immunomodulatory targets revealed. J Chemother. 20:672–683. 2008.PubMed/NCBI View Article : Google Scholar

40 

Cao YZ, Tu YY, Chen X, Wang BL, Zhong YX and Liu MH: Protective effect of Ulinastatin against murine models of sepsis: Inhibition of TNF-α and IL-6 and augmentation of IL-10 and IL-13. Exp Toxicol Pathol. 64:543–547. 2012.PubMed/NCBI View Article : Google Scholar

41 

Lv R, Zhao J, Lei M, Xiao D, Yu Y and Xie J: IL-33 attenuates sepsis by inhibiting IL-17 receptor signaling through upregulation of SOCS3. Cell Physiol Biochem. 42:1961–1972. 2017.PubMed/NCBI View Article : Google Scholar

42 

Franco DM, Arevalo-Rodriguez I, Roqué IFM, Oleas NG, Nuvials X and Zamora J: Plasma interleukin-6 concentration for the diagnosis of sepsis in critically ill adults. Cochrane Database Syst Rev. 4(CD011811)2019.PubMed/NCBI View Article : Google Scholar

43 

Newham P, Ross D, Ceuppens P, Das S, Yates JW, Betts C, Reens J, Randall KJ, Knight R and McKay JS: Determination of the safety and efficacy of therapeutic neutralization of tumor necrosis factor-α (TNF-α) using AZD9773, an anti-TNF-α immune Fab, in murine CLP sepsis. Inflamm Res. 63:149–160. 2014.PubMed/NCBI View Article : Google Scholar

44 

Collighan N, Giannoudis PV, Kourgeraki O, Perry SL, Guillou PJ and Bellamy MC: Interleukin 13 and inflammatory markers in human sepsis. Br J Surg. 91:762–768. 2004.PubMed/NCBI View Article : Google Scholar

45 

Chen L, Liu P, Feng X and Ma C: Salidroside suppressing LPS-induced myocardial injury by inhibiting ROS-mediated PI3K/Akt/mTOR pathway in vitro and in vivo. J Cell Mol Med. 21:3178–3189. 2017.PubMed/NCBI View Article : Google Scholar

46 

Hsiao YW, Tsai YN, Huang YT, Liu SH, Lin YJ, Lo LW, Hu YF, Chung FP, Lin SF, Chang SL, et al: Rhodiola crenulata reduces ventricular arrhythmia through mitigating the activation of IL-17 and inhibiting the MAPK signaling pathway. Cardiovasc Drugs Ther. 35:889–900. 2020.PubMed/NCBI View Article : Google Scholar

47 

Yan GH and Choi YH: Salidroside attenuates allergic airway inflammation through negative regulation of nuclear factor-kappa B and p38 mitogen-activated protein kinase. J Pharmacol Sci. 126:126–135. 2014.PubMed/NCBI View Article : Google Scholar

48 

Liu J, Liu F, Liang T, Cao P, Li J, Zhang Y and Liu Y: Efficacy of Shenfu decoction on sepsis in rats with condition induced by cecal ligation and puncture. J Tradit Chin Med. 40:621–628. 2020.PubMed/NCBI View Article : Google Scholar

49 

Xie S, Yang T, Wang Z, Li M, Ding L, Hu X and Geng L: Astragaloside IV attenuates sepsis-induced intestinal barrier dysfunction via suppressing RhoA/NLRP3 inflammasome signaling. Int Immunopharmacol. 78(106066)2020.PubMed/NCBI View Article : Google Scholar

50 

Meng ZJ, Wang C, Meng LT, Bao BH, Wu JH and Hu YQ: Sodium tanshinone IIA sulfonate attenuates cardiac dysfunction and improves survival of rats with cecal ligation and puncture-induced sepsis. Chin J Nat Med. 16:846–855. 2018.PubMed/NCBI View Article : Google Scholar

51 

Hwang JS, Kim KH, Park J, Kim SM, Cho H, Lee Y and Han IO: Glucosamine improves survival in a mouse model of sepsis and attenuates sepsis-induced lung injury and inflammation. J Biol Chem. 294:608–622. 2019.PubMed/NCBI View Article : Google Scholar

52 

Sun S, Wang J, Wang J, Wang F, Yao S and Xia H: Maresin 1 mitigates sepsis-associated acute kidney injury in mice via inhibition of the NF-κB/STAT3/MAPK pathways. Front Pharmacol. 10(1323)2019.PubMed/NCBI View Article : Google Scholar

53 

Chang NC, Yeh CT, Lin YK, Hu P, Kuo KT, Fong IH, Kounis NG, Hu P and Hung MY: Garcinol attenuates lipoprotein(a)-induced oxidative stress and inflammatory cytokine production in ventricular cardiomyocyte through α7-nicotinic acetylcholine receptor-mediated inhibition of the p38 MAPK and NF-κB signaling pathways. Antioxidants (Basel). 10(461)2021.PubMed/NCBI View Article : Google Scholar

54 

Chen Q, Lu H, Duan C, Zhu X, Zhang Y, Li M and Zhang D: PDCD4 simultaneously promotes microglia activation via PDCD4-MAPK-NF-κB positive loop and facilitates neuron apoptosis during neuroinflammation. Inflammation. 45:234–252. 2022.PubMed/NCBI View Article : Google Scholar

55 

Jarisarapurin W, Kunchana K, Chularojmontri L and Wattanapitayakul SK: Unripe carica papaya protects methylglyoxal-invoked endothelial cell inflammation and apoptosis via the suppression of oxidative stress and Akt/MAPK/NF-κB signals. Antioxidants (Basel). 10(1158)2021.PubMed/NCBI View Article : Google Scholar

56 

Weber SU, Schewe JC, Putensen C, Stüber F and Schröder S: Apoptosis as a pathomechanism in sepsis. Anaesthesist. 53:59–65. 2004.PubMed/NCBI View Article : Google Scholar : (In German).

57 

Li R, Guo Y, Zhang Y, Zhang X, Zhu L and Yan T: Salidroside ameliorates renal interstitial fibrosis by inhibiting the TLR4/NF-κB and MAPK signaling pathways. Int J Mol Sci. 20(1103)2019.PubMed/NCBI View Article : Google Scholar

58 

Hata K, Andoh A, Shimada M, Fujino S, Bamba S, Araki Y, Okuno T, Fujiyama Y and Bamba T: IL-17 stimulates inflammatory responses via NF-kappaB and MAP kinase pathways in human colonic myofibroblasts. Am J Physiol Gastrointestinal Liver Physiol. 282:G1035–G1044. 2002.PubMed/NCBI View Article : Google Scholar

59 

Hwang SY, Kim JY, Kim KW, Park MK, Moon Y, Kim WU and Kim HY: IL-17 induces production of IL-6 and IL-8 in rheumatoid arthritis synovial fibroblasts via NF-kappaB- and PI3-kinase/Akt-dependent pathways. Arthritis Res Ther. 6:R120–R128. 2004.PubMed/NCBI View Article : Google Scholar

60 

He S, Zhao J, Xu X, Cui X, Wang N, Han X, Guo Y and Liu Q: Uncovering the molecular mechanism of the Qiang-Xin 1 formula on sepsis-induced cardiac dysfunction based on systems pharmacology. Oxid Med Cell Longev. 2020(3815185)2020.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Liao R, Zhao P, Wu J and Fang K: Salidroside protects against intestinal barrier dysfunction in septic mice by regulating IL‑17 to block the NF‑κB and p38 MAPK signaling pathways. Exp Ther Med 25: 89, 2023.
APA
Liao, R., Zhao, P., Wu, J., & Fang, K. (2023). Salidroside protects against intestinal barrier dysfunction in septic mice by regulating IL‑17 to block the NF‑κB and p38 MAPK signaling pathways. Experimental and Therapeutic Medicine, 25, 89. https://doi.org/10.3892/etm.2023.11788
MLA
Liao, R., Zhao, P., Wu, J., Fang, K."Salidroside protects against intestinal barrier dysfunction in septic mice by regulating IL‑17 to block the NF‑κB and p38 MAPK signaling pathways". Experimental and Therapeutic Medicine 25.2 (2023): 89.
Chicago
Liao, R., Zhao, P., Wu, J., Fang, K."Salidroside protects against intestinal barrier dysfunction in septic mice by regulating IL‑17 to block the NF‑κB and p38 MAPK signaling pathways". Experimental and Therapeutic Medicine 25, no. 2 (2023): 89. https://doi.org/10.3892/etm.2023.11788
Copy and paste a formatted citation
x
Spandidos Publications style
Liao R, Zhao P, Wu J and Fang K: Salidroside protects against intestinal barrier dysfunction in septic mice by regulating IL‑17 to block the NF‑κB and p38 MAPK signaling pathways. Exp Ther Med 25: 89, 2023.
APA
Liao, R., Zhao, P., Wu, J., & Fang, K. (2023). Salidroside protects against intestinal barrier dysfunction in septic mice by regulating IL‑17 to block the NF‑κB and p38 MAPK signaling pathways. Experimental and Therapeutic Medicine, 25, 89. https://doi.org/10.3892/etm.2023.11788
MLA
Liao, R., Zhao, P., Wu, J., Fang, K."Salidroside protects against intestinal barrier dysfunction in septic mice by regulating IL‑17 to block the NF‑κB and p38 MAPK signaling pathways". Experimental and Therapeutic Medicine 25.2 (2023): 89.
Chicago
Liao, R., Zhao, P., Wu, J., Fang, K."Salidroside protects against intestinal barrier dysfunction in septic mice by regulating IL‑17 to block the NF‑κB and p38 MAPK signaling pathways". Experimental and Therapeutic Medicine 25, no. 2 (2023): 89. https://doi.org/10.3892/etm.2023.11788
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team